EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 39 filers reported holding EVOGENE LTD in Q1 2022. The put-call ratio across all filers is 4.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,554 | -45.3% | 59,007 | 0.0% | 0.00% | – |
| Q2 2023 | $63,137 | +69.8% | 59,007 | 0.0% | 0.00% | – |
| Q1 2023 | $37,174 | +90568.3% | 59,007 | 0.0% | 0.00% | – |
| Q4 2022 | $41 | -99.9% | 59,007 | 0.0% | 0.00% | – |
| Q3 2022 | $48,000 | +6.7% | 59,007 | 0.0% | 0.00% | – |
| Q2 2022 | $45,000 | -40.8% | 59,007 | 0.0% | 0.00% | – |
| Q1 2022 | $76,000 | -20.8% | 59,007 | 0.0% | 0.00% | – |
| Q4 2021 | $96,000 | -38.1% | 59,007 | 0.0% | 0.00% | – |
| Q3 2021 | $155,000 | +70.3% | 59,007 | +120.7% | 0.00% | – |
| Q2 2021 | $91,000 | -4.2% | 26,731 | +40.9% | 0.00% | – |
| Q1 2021 | $95,000 | +6.7% | 18,970 | 0.0% | 0.00% | – |
| Q4 2020 | $89,000 | – | 18,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eidelman Virant Capital | 117,000 | $101,000 | 0.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,322 | $156,000 | 0.05% |
| Senvest Management, LLC | 230,606 | $178,000 | 0.01% |
| Susquehanna International Group Ltd. | 28,718 | $21,000 | 0.01% |
| Vident Investment Advisory, LLC | 87,714 | $68,000 | 0.00% |
| MGO ONE SEVEN LLC | 15,340 | $12,000 | 0.00% |
| Csenge Advisory Group | 31,962 | $24,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $8,000 | 0.00% |
| Sigma Planning Corp | 31,810 | $24,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,249 | $8,000 | 0.00% |